Kelly H W, Powell J R, Donohue J F
Clin Pharmacol Ther. 1986 May;39(5):577-81. doi: 10.1038/clpt.1986.99.
While most controlled studies in humans indicate that ranitidine does not alter drug metabolism, there is some evidence that ranitidine may have this property. If ranitidine does inhibit drug metabolism in a predictable manner, such an effect might be expressed at higher ranitidine doses. Our study was designed to contrast the effects of large doses of ranitidine (1200 and 4200 mg/day) and cimetidine (1200 mg/day) on theophylline elimination. Whereas cimetidine decreased theophylline clearance in 11 of 12 subjects by a mean of 19.4%, neither ranitidine dose affected theophylline disposition. While case reports indicate ranitidine may inhibit theophylline metabolism specifically and drug metabolism in general, we were not able in our controlled study to detect any effect of ranitidine on theophylline elimination even at ranitidine doses up to fourteenfold greater than are generally prescribed.
虽然大多数针对人类的对照研究表明雷尼替丁不会改变药物代谢,但有一些证据表明雷尼替丁可能具有这一特性。如果雷尼替丁确实以可预测的方式抑制药物代谢,那么这种效应可能在较高剂量的雷尼替丁时表现出来。我们的研究旨在对比大剂量雷尼替丁(1200毫克/天和4200毫克/天)和西咪替丁(1200毫克/天)对茶碱消除的影响。西咪替丁使12名受试者中的11名的茶碱清除率平均降低了19.4%,而两种剂量的雷尼替丁均未影响茶碱的处置。虽然病例报告表明雷尼替丁可能会特异性地抑制茶碱代谢以及总体上的药物代谢,但在我们的对照研究中,即使雷尼替丁的剂量比通常规定的剂量高出十四倍,我们也未能检测到雷尼替丁对茶碱消除有任何影响。